Skip to main content

Fiscal Wizard · Single-issue tearsheet

AKTS / Jun 21, 2026 Run #7375

AKTS

Aktis Oncology, Inc.

Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company's lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts.

Composite verdict

F 17.3 / 100
Bearish setup · Reversal 9 drivers · 2 gates blocking
  • Williams %R
  • Chaikin Money Flow
  • Bollinger Reentry
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 310th of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 0%Evidence: High · 13 signals100% Bear
Momentum Neutral 50Mean-reversion Bearish 7

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -86%

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

31.5 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Return on Assets 75
Margin of Safety 0
Greenblatt ROC 75
Free Cash Flow Yield 0
Greenblatt EY 75
P/S Ratio 25

Technicals Bearish

3.1 / 100

Bearish setup leads (Williams %R, Chaikin Money Flow, Bollinger Reentry); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Williams %R 6
Chaikin Money Flow 13
Bollinger Reentry 15

Risk Gates

2 blocking 4 caution

2 guards active, 18 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for AKTS.